Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI watches hospital Patients' vital signs to catch decline early

NCT ID NCT07649642

Knowledge-focused Sponsor: Eske Kvanner Aasvang Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether continuous, AI-driven monitoring of vital signs can help hospital staff spot when a patient's condition is worsening. About 100 adults at risk of clinical deterioration will wear sensors that track their vital signs in real time. Nurses and doctors will rate how relevant and helpful the alerts are, aiming to improve patient safety.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Continuous vital sign monitoring device with AI algorithm
What this could lead to
If successful, this could improve how hospitals detect early signs of patient decline, potentially leading to faster care.
What could go wrong
This is a small, early-stage study focused on staff feedback, not patient outcomes. The AI may not improve care or could cause alarm fatigue.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: Patients can be included if they meet all the following criteria: * Age ≥ 18 years * Patients assessed by the clinical staff as having an acute condition with risk for clinical deterioration. * Expected admission for more than 24 hours to a general ward. Exclusion criteria: Patients are excluded if they meet any of the following criteria: * Having implanted electronic devices (such as pacemaker or Implantable Cardioverter Defibrillator (ICD) device). * Known pregnancy or breastfeeding * Inability to give informed consent. * The participant expected not to cooperate with study procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Deterioration, clinical are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Clinical Deterioration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Deterioration, clinical Postoperative care

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bispebjerg Hospital

    Copenhagen, 2400, Denmark

  • Rigshospitalet

    Copenhagen, 2100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.